Abstract
A strict definition of nanotechnology characterizes it as the manipulation of atoms and molecules at the scale of approximately one-billionth of a metre (one nanometre) or smaller in size. Scientific activity at such a scale has provided enormous potential, especially in the environmental field. Nonetheless, recent studies show that nanoparticles present unique and significant health risks. These unique risks raise the questions whether the nanoscale products traded daily regulation should be subject to the WTO Agreement on the Application of Sanitary and Phytosanitary Measures (SPS Agreement) and the Technical Barriers to Trade (TBT Agreement)? If so, would the Agreements objectively balance the unique risks and benefit? An examination Agreements and WTO jurisprudence, shows that yes, the Agreements are capable of this goal. Nanotechnology, WTO, the SPS Agreement, the TBT Agreement, Environmental Risks, Business Benefits, Balance
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
